60 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
MRK Merck & Company, Inc. $70.42 $187.28B N/A
Article Searches
AstraZeneca's (AZN) Q1 Earnings Beat, New Drugs Drive Sales http://www.zacks.com/stock/news/404479/astrazenecas-azn-q1-earnings-beat-new-drugs-drive-sales?cid=CS-ZC-FT-404479 Apr 26, 2019 - AstraZeneca (AZN) beats earnings and sales estimates in the first quarter. New drugs, especially cancer drugs, drive revenues.
Merck (MRK) Tops on Q1 Earnings & Sales, Stock Up http://www.zacks.com/stock/news/405495/merck-mrk-tops-on-q1-earnings-sales-stock-up?cid=CS-ZC-FT-405495 Apr 30, 2019 - Merck (MRK) beats estimates for earnings as well as sales in first-quarter 2019. Stock is up in pre-market trading.
Merck & Co Inc. (MRK) CEO Ken Frazier on Q1 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4258153-merck-and-co-inc-mrk-ceo-ken-frazier-q1-2019-results-earnings-call-transcript?source=feed_sector_healthcare Apr 30, 2019 - Merck & Co Inc. (NYSE:MRK) Q1 2018 Earnings Conference Call April 30, 2019 8:00 AM ET Company Participants Teri Loxam - SVP, Investor Relations and Global Communications Ken Frazier - Chairman and
Company News For May 1, 2019 http://www.zacks.com/stock/news/406426/company-news-for-may-1-2019?cid=CS-ZC--406426 May 01, 2019 - Companies in the news are: GE, GM, MRK and MA
Are You Looking for a High-Growth Dividend Stock? Merck (MRK) Could Be a Great Choice http://www.zacks.com/stock/news/407489/are-you-looking-for-a-high-growth-dividend-stock-merck-mrk-could-be-a-great-choice?cid=CS-ZC-FT-407489 May 02, 2019 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Merck (MRK) have what it takes? Let's find out.
Pharma Stock Roundup: MRK, LLY, PFE Report Q1 Earnings, SNY, ABBV Drugs Get EU Nod http://www.zacks.com/stock/news/408311/pharma-stock-roundup-mrk-lly-pfe-report-q1-earnings-sny-abbv-drugs-get-eu-nod?cid=CS-ZC-FT-408311 May 03, 2019 - Merck (MRK), Pfizer (PFE), Lilly (LLY) announce Q1 results. European Commission grants approval to AbbVie's (ABBV) Skyrizi and Sanofi's (SNY) Zynquista.
The Zacks Analyst Blog Highlights: Merck, Pfizer, AbbVie, Sanofi and Glaxo http://www.zacks.com/stock/news/409269/the-zacks-analyst-blog-highlights-merck-pfizer-abbvie-sanofi-and-glaxo?cid=CS-ZC-FT-409269 May 06, 2019 - The Zacks Analyst Blog Highlights: Merck, Pfizer, AbbVie, Sanofi and Glaxo
Aduro (ADRO) Q1 Earnings and Revenues Fall Shy of Estimates http://www.zacks.com/stock/news/411257/aduro-adro-q1-earnings-and-revenues-fall-shy-of-estimates?cid=CS-ZC-FT-411257 May 08, 2019 - Aduro (ADRO) suspends the BION-1301 program for MM in Q1 due to severe competition.
Intercept (ICPT) Q1 Earnings Miss Estimates, Revenues Beat http://www.zacks.com/stock/news/412101/intercept-icpt-q1-earnings-miss-estimates-revenues-beat?cid=CS-ZC-FT-412101 May 09, 2019 - Intercept's (ICPT) Q1 revenues top estimates on strong Ocaliva sales, driven by sales force expansion.
Endo (ENDP) Q1 Earnings & Revenues Beat Estimates http://www.zacks.com/stock/news/412848/endo-endp-q1-earnings-revenues-beat-estimates?cid=CS-ZC-FT-412848 May 10, 2019 - Endo's (ENDP) earnings and revenues top expectations in the first quarter of 2019.

Pages: 123456

<<<Page 4>